Advertisement
Advertisement

PSTV

PSTV logo

PLUS THERAPEUTICS, Inc. Common Stock

0.24
USD
Sponsored
+0.01
+3.89%
Feb 06, 15:20 UTC -5
Open

PSTV Earnings Reports

Positive Surprise Ratio

PSTV beat 24 of 40 last estimates.

60%

Next Report

Date of Next Report
Mar 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.56M
/
-$0.03
Implied change from Q3 25 (Revenue/ EPS)
+11.66%
/
-25.00%
Implied change from Q4 24 (Revenue/ EPS)
+10.48%
/
-93.88%

PLUS THERAPEUTICS, Inc. Common Stock earnings per share and revenue

On Oct 30, 2025, PSTV reported earnings of -0.04 USD per share (EPS) for Q3 25, missing the estimate of -0.02 USD, resulting in a -96.08% surprise. Revenue reached 1.40 million, compared to an expected 1.53 million, with a -8.69% difference. The market reacted with a +2.45% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.03 USD, with revenue projected to reach 1.56 million USD, implying an decrease of -25.00% EPS, and increase of 11.66% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, PLUS THERAPEUTICS, Inc. Common Stock reported EPS of -$0.04, missing estimates by -96.08%, and revenue of $1.40M, -8.69% below expectations.
The stock price moved up 2.45%, changed from $0.53 before the earnings release to $0.54 the day after.
The next earning report is scheduled for Mar 25, 2026.
Based on 6 analysts, PLUS THERAPEUTICS, Inc. Common Stock is expected to report EPS of -$0.03 and revenue of $1.56M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement